Proteomic Panel for Lung Cancer
- Aliases
-
- Proteomic Panel for Lung Cancer
- Description
- An immunoaffinity-mass spectrometry-based quantification approach was used to develop an assay for verifying the expression of potential biomarkers in patient serum samples from lung cancer patients.
Attributes
- QA State
- Curated
- Type
- Proteomic
- HGNC Name
- Certifications
-
- None
- QA State for Lung
- Curated
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.
- No resources were specified for this biomarker.
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.